STOCK TITAN

Paradigm Capital discloses 4.42% Integra LifeSciences (IART) stake with sole voting control

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Integra LifeSciences Holdings Corp’s common stock has a reported significant shareholder, Paradigm Capital Management, Inc., as updated in an amended ownership report. Paradigm Capital Management, a New York S corporation based in Albany, reports beneficial ownership of 3,439,098 shares of Integra LifeSciences common stock.

This position represents 4.42% of the outstanding common stock of Integra LifeSciences. Paradigm Capital Management reports sole power to vote and dispose of all 3,439,098 shares, with no shared voting or dispositive power. The filing characterizes the holding as ownership of 5 percent or less of the class, reflecting its current status relative to regulatory reporting thresholds.

Positive

  • None.

Negative

  • None.
Beneficially owned shares 3,439,098 shares Common stock beneficially owned by Paradigm Capital Management, Inc.
Percent of class 4.42% Percentage of Integra LifeSciences common stock class held by Paradigm Capital Management, Inc.
Sole voting power 3,439,098 shares Shares over which Paradigm Capital Management, Inc. has sole power to vote or direct the vote
Sole dispositive power 3,439,098 shares Shares over which Paradigm Capital Management, Inc. has sole power to dispose
Ownership threshold characterization 5 percent or less Ownership of 5 percent or less of a class, as stated in Item 5
beneficially owned financial
"Amount beneficially owned: 3,439,098"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole power to vote financial
"Sole power to vote or to direct the vote: 3,439,098"
sole power to dispose financial
"Sole power to dispose or to direct the disposition of: 3,439,098"
Ownership of 5 percent or less of a class regulatory
"Item 5. Ownership of 5 Percent or Less of a Class."

FAQ

What percentage of Integra LifeSciences (IART) shares does Paradigm Capital Management report owning?

Paradigm Capital Management reports owning 4.42% of Integra LifeSciences’ common stock. This corresponds to 3,439,098 shares and is characterized as ownership of five percent or less of the class.

How many Integra LifeSciences (IART) shares are beneficially owned by Paradigm Capital Management?

Paradigm Capital Management reports beneficial ownership of 3,439,098 shares of Integra LifeSciences common stock. All these shares are reported with sole voting and sole dispositive power and no shared authority.

Does Paradigm Capital Management have sole or shared voting power over its Integra LifeSciences (IART) shares?

Paradigm Capital Management reports sole power to vote or direct the vote over 3,439,098 shares and no shared voting power. It likewise has sole power to dispose of the same number of shares.

What type of entity is Paradigm Capital Management in relation to its Integra LifeSciences (IART) holdings?

Paradigm Capital Management is described as a New York S corporation with its principal business office at 9 Elk Street, Albany, NY 12207. It reports beneficial ownership and control of the disclosed Integra LifeSciences shares.

How does the filing describe Paradigm Capital Management’s ownership level in Integra LifeSciences (IART)?

The ownership is described as 4.42% of the class and is further characterized as ownership of five percent or less of Integra LifeSciences’ common stock, indicating its status relative to reporting thresholds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





457985208

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



PARADIGM CAPITAL MANAGEMENT INC/NY
Signature:Richard J Gimon
Name/Title:Chief Compliance Officer
Date:08/13/2026